chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of headache in a adult female patient who received SHINGRIX. Previously administered products included SHINGRIX with an associated reaction of influenza like illness (1st dose (see case US2018079563)). On 2nd May 2018, the patient received the 2nd dose of SHINGRIX .5 ml. On 2nd May 2018, less than a day after receiving SHINGRIX, the patient experienced influenza-like symptoms. In May 2018, the patient experienced headache, fever, chills, general body pain, feeling unwell, enlargement of lymph nodes, skin warm, sweating and nausea. On an unknown date, the outcome of the headache, fever, chills and general body pain were recovered/resolved and the outcome of the feeling unwell and skin warm were unknown and the outcome of the influenza-like symptoms, enlargement of lymph nodes and sweating were unchanged and the outcome of the nausea was recovering/resolving. The reporter considered the headache, fever, chills, general body pain, feeling unwell, influenza-like symptoms, enlargement of lymph nodes, sweating and nausea to be related to SHINGRIX. It was unknown if the reporter considered the skin warm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX vaccine on left deltoid. The patient noted that she experienced side effects with 2nd dose of the SHINGRIX vaccine. The patient had the same side effects as the 1st dose but the events were more intense. Yesterday morning within 24 hours on 3rd May 2018, the patient was not feeling well and felt like she was having flu like symptoms. This time with the chills, she felt like she could never get warm until this morning. The patient noticed today that her left armpit felt funny. When she went to look in the mirror, she saw an enlarged lymph node. She said it was in the lower part of her armpit, literally in the crease near her breast. She was asked if she could describe the size of the lymph node. She stated that if felt like it was about 2 and half inches in diameter. It was not on the surface, just under her skin in the armpit and it felt warm to the touch. The patient explained that she had been sweating and it was more than what would be normal to her because she rarely sweats. She was not able to speak to her doctor, but it was suggested that she go to urgent care for treatment. This case has been linked with US2018079563, reported for 1st dose of SHINGRIX for the same patient.
Lips dry, patient pale and faint, not alert, syncopal episode, eyes open 2-3 seconds.
48 hour of headache, diarrhea, body pain, sight swelling red and blistered for 4 days now red gone just swollen today
The patient was feeling nauseous after being vaccinated.  It  was then determined that the patient is in early weeks of pregnancy and was given MMR and Varivax in error (unknown how far along pt is)--contacted MD, waiting for MD to call us back.  Advised patient to follow up with MD.
Information has been received from a physician concerning a 12 year old female who on 02-AUG-2007 was vaccinated with GARDASIL (dose unspecified). On 02-AUG-2007 the patient experienced fever and felt ill. Subsequently, this lasted 48-72 hours. The patient sought unspecified medical treatment. No further information was provided. Additional information has been requested.
lightheaded, nausea, dizzy through series; checked titer in SEP-titer extremely low;
I HAD VERY SHARP AND SEVERE NERVE PAINS TRAVELING DOWN MY LEFT LEG - THE PAINS WERE SUDDEN, DISABLING, INTERMITTENT BUT ONLY LASTED FOR A FEW SECONDS.  DURING THE FIRST HOUR OR SO FOLLOWING THE INJECTION I PROBABLY HAD ABOUT 20 OF THE PAINS - AS THE DAY CONTINUED THEY BEGAN DIMINISHING SO THAT I ONLY HAD ABOUT 3 OR 4 PER HOUR - PRIOR TO BEDTIME - I ONLY HAD ABOUT THREE DURING THE NIGHT - ABD THE FOLLOWING DAY THEY HAD DIMINSHED SO THAT THE LAST ONES I RECALL WERE THE MORNING OF THE 11TH.  I TOOK OTC PAIN RELIEVER ADVIL ON A CONTINUING BASIS AROUND THE CLOCK AS I ALSO HAD MUCH PAIN AND SWELLING AROUND THE INJECTION SITE WHICH AS OF THIS DATE (THE 12TH) HAS GREATLY IMPROVED BUT STILL PRESENT.
Patient given Moderna vaccine at age 17 during the time of injection. No adverse reactions. Patient tolerated well.
I went  to the Hospital for 2nd COVID shot waited my 15 minutes. I went home after that feeling fine. The next day I woke up and my heart rate kept going up very high. It was like for 6 days I spoke to my doctor and they just recommended rest no medication. It started subsided on its own after that.
Facial numbness especially over the lips, spreading from chin to eyes sockets; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown; formulation: solution for injection; expiration date: unknown), via an unspecified route of administration on left arm on 08Feb2021 at 19:00 (at the age of 57-years-old) at single dose for covid-19 immunisation at Doctor's office/urgent care. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had allergies to percocet [oxycodone hydrochloride; oxycodone terephthalate; paracetamol] and experienced drug allergy (hypersensitivity). Concomitant medications in two weeks included loratadine (LORATADINE), thyroid (ARMOUR THYROID) both were taken for an unspecified indication and start and stop date were not reported. The patient previously received first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on unspecified date at single dose for covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Feb2021 at 06:00 The patient experienced facial numbness especially over the lips, spreading from chin to eyes sockets. The patient did not received treatment for the events. The outcome of the event was recovered on unspecified date.  Information on the lot/batch number has been requested.
A non-serious, spontaneous report of jerked a little and got some i nhis eye was received from a consumer concerning a 33-month-old male. Neither medical history nor concomitant medications were reported. On 06-Oct-2009 the patient jerked during administration and the FLUMIST was sprayed in the eye. There was no adverse event associated with the medication error; therefore, treatment and reporter/sponser causality assessments are not applicable, and the event is considered resolved. All follow-ups have been completed per company.  No futher information is available. 10 Mar 2010.
Provider administered Moderna Bivalent Booster 0.2ML (NDC 80777-0283-99) instead of Moderna Bivalent dose 0.25ML (NDC 00777-282-99) as 2nd dose in primary series. No adverse reaction
bone pain; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced BONE PAIN (bone pain). On 06-Mar-2021, BONE PAIN (bone pain) had resolved. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medications include Blood pressure medication and Vitamins  No treatment information was provided   This case was linked to US-MODERNATX, INC.-MOD-2021-067331 (E2B Linked Report). This case was linked to MOD-2021-067331 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067331:
Immunization/vaccinia placed 14 Mar 07.  Had left shoulder pain  extending into left pectoralis major musculature with minimal localized erythema.  Fever of 100.7 with headache, myalgias consistent with inflammatory response and viral syndrome.  Had normal WBC count, and treated with NSAIDS and monitoring.
Coughing; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced COUGH (Coughing). At the time of the report, COUGH (Coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment was reported for the events.
RN (Contract Staff) gave ZOSTER instead of Varicella to a 3 month old child. Notified Pharmacy, MD, and agency w/I 1 hour of occurrence. Instructed by agency to complete VAERS. MD to follow-up with parent and patient. Nurse manager informed regarding administering RN.
I have swelling and pain in injection arm 19 days after vaccine! I had mild pain a day after that went away but now arm is very achey!
At about 12:45 a.m. on March 29th, I was awakened by sharp stabbing pains in my right side - lower back/kidney area, and a similar pain in my at the top of my knee where the lower thigh bone connects to the bend at the top of the knee.
Localized reaction to MENVEO - swelling, painful, warm to touch, onset about one hour after injection on 11-1-16 - improved at office visit on 11-4-16.
Patient has no side effects to report at this time.  Patient requested  the Bivalent Pfizer vaccine and was given Monovalent Pfizer vaccine.
This case was reported by a physician and described the occurrence of fever in a 6-month-old female subject who was vaccinated with PEDIARIX, (GlaxoSmithKline) and DAPTACEL (non-GSK). On an unspecified date, the subject received an unspecified dose of PEDIARIX (unknown route and injection site, batch number not provided). On the same day, the subject also received an unspecified dose of DAPTACEL (unknown route and injection site) instead of Hib vaccine which led to an overdose for DTPa antigens. At an unspecified time after vaccination with DAPTACEL and PEDIARIX, the subject experienced fever and lethargy. After 48 hours, the events were resolved. The physician considered the events were possibly related to vaccination with PEDIARIX and DAPTACEL.
Pt presented with redness and swelling at injection site of the left thigh. No fever/chills.
Information has been received from a physician concerning an approximately 3 months old female patient with no concomitant medications, no pertinent medical history and no drug reactions/allergy reactions, who was vaccinated with the first dose of ROTATEQ (lot# not provided) one pouch orally. 2 weeks later the patient was admitted to the hospital for idiopathic thrombocytopenic purpura (ITP). It was reported that on admission the patient's platelet count was 3000. She was hospitalized for 2 days and was treated with intravenous immunoglobulin (IVIG). On 18-NOV-2008 the patient's platelet count was 128000. Physician recommended that the patient not receive any additional doses of ROTATEQ. At the time of this report the patient was recovering. Additional information has been requested.
Every since mother got this injection, she has been sick. Her illness started Aug 2019. She is now in Hospital, no one knows what she has and she is dying. It has gotten worse and worse until the point of now. Which they are saying she has less than a month to live. I need to know what the others got from these injections. A lawyer has gone after this clinic. I need help treating my mother.
6/22/10 was given PNEUMOVAX injection in Lt. deltoid.  He called out office 6/23/10 c/o red, itchy, swollen and tender Lt deltoid area 4 X 4 area of redness.  Site tenderness Lt. arm sore from Lt. shoulder to elbow. Treatment BENADRYL, ice, TYLENOL.  He is to call if worsening symptoms.
PATIENT WAS GIVEN 3 DOSES INSTEAD OF THE RECOMMENDED 2 DOSES OF SHINGRIX. THE ADMINISTRATION ERROR WAS DISCOVERED AFTER PATIENT REQUESTED A YEARLY REPORT AND SHE SAW 3 DOSES OF SHINGRIX. THE PATIENT SAID SHE REMEMBERED A SORE ARM AFTER THE INJECTION.
(L) deltoid erythematous, warm & firm to palpation. Very tender. Cool compress, TYLENOL or MOTRIN for comfort.
Shot given on 3/27, on 4/2 I woke with a horrible case of vertigo. The dizziness got so bad went to a urgent care. Was given medication to help stop the spinning. Still felt bad for 4 days.  Not sure if it was from the shot or not but due to that being the only chance in my life might as well report.
hair loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair loss) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included SIMVASTATIN, TRANEXAMIC ACID (LYSTEDA), OMEPRAZOLE, VITAMIN D2, LISINOPRIL, METOPROLOL, METFORMIN, PROGESTERONE, SPIRONOLACTONE and PHENTERMINE HYDROCHLORIDE, TOPIRAMATE (QSYMIA) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced ALOPECIA (hair loss). At the time of the report, ALOPECIA (hair loss) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drug include Qsymia-15/92 mg dose.  Treatment information not provided.
1400 1ST Moderna felt dizziness and SOB. 1408 Epi Pen 0.3 ml IM left thigh SPO2 99% Patient extensive work of breathing was unable to catch breath was in respiratory distress. No audible wheeze, pulm exam was clear. Following  Epi pen administration , shaky experienced chills, HX Guillain Barre Syndrome. 1427 Resting lying Supine 1431 25 mg IM Benadryl given by EMS 1439 Transported by EMS to ER
Irregular menstrual cycle. Cycle length has shortened significantly, with only a few days to a week between bleeding.  This has been the case for over a year now.
After I received the shot in the night time started to feel sore felt that way for a few hours until I fell asleep woke up the next morning feeling better.
1 of 2 teenagers (FROM TAIWAN) recv vax & exp an inj site rxn described as red & swollen;recovered;TB test given the same day;
developed bursitis; This spontaneous case was reported by a consumer and describes the occurrence of BURSITIS (developed bursitis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURSITIS (developed bursitis). The patient was treated with METHYLPREDNISOLONE ACETATE (DEPO-MEDROL) for Bursitis, at an unspecified dose and frequency and LIDOCAINE for Bursitis, at an unspecified dose and frequency. At the time of the report, BURSITIS (developed bursitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. It was reported that patient got the Covid 19 shot and in sometime patient developed bursitis. Patient went to orthopedic surgeon; they gave patient Depo Medrol steroid shot in shoulder area and mixed it with lidocaine for numbing agent. Before they injected patient noticed that the liquid in the syringe was cloudy. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
complains of persistent left arm pain at rest since receiving vaccine 12/10/2008. doesnt affect his arm during exertion but aches at night
Flu like symptoms. Mostly headache, nausea, and feeling hot; Flu like symptoms. Mostly headache, nausea, and feeling hot.; Flu like symptoms. Mostly headache, nausea, and feeling hot.; Flu like symptoms. Mostly headache, nausea, and feeling hot.; This is a spontaneous report from a non-contactable consumer. A 12-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 12Jun2021 at 08:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in May2021 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Jun2021 at 08:00, the patient experienced flu like symptoms, mostly headache, nausea, and feeling hot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms, mostly headache, nausea, and feeling hot was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
fullness/stuffiness in nasal; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (fullness/stuffiness in nasal) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced NASAL CONGESTION (fullness/stuffiness in nasal). At the time of the report, NASAL CONGESTION (fullness/stuffiness in nasal) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXIA 1/25/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
6/21 sore arm, swollen arm, fever 6/22, and malaise. Continued 6/23, 6/24 arm worse and couldn't raise arm, rash and induration at site, rash on outer aspect of arm, sore throat 6/25 3:30AM pain upper chest, shoulder blade and down arm.
1/17/21 midnight-fever as high as 103.8, chills, sweats, mental confusing, imbalance, weakness, COVID like symptoms (PT tested positive for COVID 11/21/20, patient had to take 2 aspirin to help with side effects.   Present-sweating, chills, fever, ibuprofen/Tylenol rotated as needed
Left arm was itchy; Top of arm 4 inch down was red, hot and had a hard lump; covid arm; Top of arm 4 inch down was red, hot and had a hard lump; Top of left arm 4 inch down was red, hot and had a hard lump; Slight fever of 98.4-98.6; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Left arm was itchy), AXILLARY MASS (Top of arm 4 inch down was red, hot and had a hard lump), VACCINATION SITE REACTION (covid arm), FEELING HOT (Top of arm 4 inch down was red, hot and had a hard lump) and ERYTHEMA (Top of left arm 4 inch down was red, hot and had a hard lump) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included AFib in 2019. Previously administered products included for Product used for unknown indication: Flu shot in October 2021. Past adverse reactions to the above products included No adverse event with Flu shot. Concurrent medical conditions included Cancer. Concomitant products included APIXABAN (ELIQUIS), DILTIAZEM and LEVOTHYROXINE for an unknown indication.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 29-Oct-2021, the patient experienced PRURITUS (Left arm was itchy), AXILLARY MASS (Top of arm 4 inch down was red, hot and had a hard lump), VACCINATION SITE REACTION (covid arm), FEELING HOT (Top of arm 4 inch down was red, hot and had a hard lump), ERYTHEMA (Top of left arm 4 inch down was red, hot and had a hard lump) and PYREXIA (Slight fever of 98.4-98.6). On 31-Oct-2021, PYREXIA (Slight fever of 98.4-98.6) had resolved. On 01-Nov-2021, ERYTHEMA (Top of left arm 4 inch down was red, hot and had a hard lump) had resolved. At the time of the report, PRURITUS (Left arm was itchy), AXILLARY MASS (Top of arm 4 inch down was red, hot and had a hard lump), VACCINATION SITE REACTION (covid arm) and FEELING HOT (Top of arm 4 inch down was red, hot and had a hard lump) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Oct-2021, Body temperature: 98.4-98.6 (Low) slight fever of 98.4-98.6.         No treatment medication was reported.   This case was linked to MOD-2021-370414 (Patient Link).
pt recv vax 12APR95 & 14APR95 devel red warm pimple like rash across lt chest, red blotchy rash from lt shoulder to lt elbow; swelling also noted went to MD 18APR95; placed on PCN due to ?infect; Is to return to MD 19APR95;
There was no adverse event but after administration of the MCV4, the nurse realized that the 11 year old had received a MCV4 last year on 8/09/2009.
Patient complained of "feeling  tingling/pickly in face and arms".  Denies SOB or tongue swelling/numbness.  Denies any issues with first vaccine.  Headache started.  Stated she had headache with the first dose. Cold wash clothes to forehead and back of neck.  Felt better.  Discharged home.
This spontaneous report was received from a pharmacist refers to 3 unspecified patients of unknown age and gender. On an unknown date, the 3 patients was vaccinated with a dose of PNEUMOVAX23 (lot# reported as H016295, expiry: November 2013). On an unknown date, the 3 patients experienced severe arm swelling and pain after receiving PNEUMOVAX23. The outcome of severe arm swelling and pain was unknown. Additional information has been requested.
high fever cough chest and back pain run down achy allover went to dr done chestxrays flu swab diagnosed w/pneumonia
Information has been received from a case (MARRS # 1207USA003929) regarding a male who received a dose of ROTATEQ on 30-AUG-2003 and experienced "obstructed bowel movements." It was also noted that the physician reported that the patient was constipated because the mother was feeding him too much. No additional information was received.
This is a spontaneous report from a contactable physician and from a contactable nurse via a Pfizer sales representative. These physician and nurse reported similar events for 6 patients. This is the 5th of six reports. An approximately 16 year-old patient of an unspecified race, ethnicity and gender received the first single dose of TRUMENBA via an unspecified route of administration on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced rash\hives following the vaccination on an unspecified date. Symptoms were moderate and resolved after few days on an unspecified date. Sender's Comments: Linked Report(s) : US-PFIZER INC-2017286355 same reporter/product/events, different patient.
Server abdominal pain around incision area. Cat scan revealed nothing wrong. Gabapentin prescribed for the pain. Systems disappeared 4 weeks later